Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Economic Evaluation of Anti-Epileptic Medicines for Autistic Children with Epilepsy

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Peer Reviewed:
      Y
    • المصدر:
      9
    • الموضوع:
      Foreign Countries; Autism Spectrum Disorders; Epilepsy; Pharmacology; Drug Therapy; Children; Health Care Costs
    • الموضوع:
      Italy; Spain; United Kingdom (England); Ireland
    • الرقم المعرف:
      10.1007/s10803-023-05941-8
    • ISSN:
      0162-3257
      1573-3432
    • نبذة مختصرة :
      We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure.
    • نبذة مختصرة :
      As Provided
    • الموضوع:
      2024
    • الرقم المعرف:
      EJ1433061